FdaApplication
NDA 204168
Identifiers
- fda_app_no: NDA204168
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 2013-07-25 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | EQ 20MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | EQ 120MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | EQ 40MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | EQ 80MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
4 products